Left ventricular (LV) mass is affected by cardiovascular diseases and
disorders. An increase in LV mass during a disease process may suggest
disease progression, while a decrease in mass may suggest disease reg
ression. Thus, LV mass can be used to follow the natural history of a
disease or disorder and to evaluate the effect of therapeutic interven
tions. Although several methods have been used to determine LV mass in
clinical practice, their application requires knowledge of their limi
tations and advantages. Most such techniques are insufficiently sensit
ive or specific to define LV mass changes in individual patients. Cons
equently, it may be more beneficial to evaluate therapy-related change
s in LV mass in large patient groups.